Medical Cannabis - Poland

Poland

Poland is expected to see revenue in the Medical Cannabis market market reach US$24.54m in 2024.
This revenue is projected to demonstrate an annual growth rate (CAGR 2024-2029) of 3.32%, leading to a market volume of US$28.89m by 2029.
When compared globally, the United States is anticipated to generate the highest revenue, amounting to US$14,530.00m in 2024.
On a per person basis, revenues of US$1.80k are expected to be generated in Poland in 2024.
Poland's medical cannabis market shows promise with increasing research initiatives and growing acceptance for therapeutic applications.

Key regions: Australia, Europe, South Africa, United States, Netherlands

Market

Region

Region comparison

Currency

Analyst Opinion

Amidst the changing landscape of cannabis regulations across Europe, Poland has emerged as a key player in the Medical Cannabis market.

Customer preferences: Patients in Poland are increasingly turning to Medical Cannabis as an alternative treatment option for various medical conditions. This shift in consumer behavior can be attributed to the growing awareness of the potential therapeutic benefits of cannabis products. Additionally, the preference for natural remedies and the desire to explore new treatment options are driving more individuals towards Medical Cannabis.

Trends in the market: One prominent trend in the Medical Cannabis market in Poland is the expanding product offerings and availability. As regulations evolve and become more favorable towards medical cannabis, more companies are entering the market and diversifying their product range to cater to different patient needs. This trend is not only providing patients with a wider selection of treatment options but also fostering competition and innovation within the industry.

Local special circumstances: Poland's unique regulatory environment plays a significant role in shaping the Medical Cannabis market. The country has strict regulations in place governing the cultivation, distribution, and use of medical cannabis, which ensures product quality and patient safety. Moreover, the increasing support from healthcare professionals and the government for the use of Medical Cannabis is contributing to the market's growth and legitimacy in Poland.

Underlying macroeconomic factors: The economic landscape in Poland, characterized by steady economic growth and increasing healthcare expenditures, is also fueling the development of the Medical Cannabis market. As the healthcare sector continues to expand and modernize, there is a growing acceptance of alternative medical treatments like Medical Cannabis. Additionally, the rising disposable income levels among the population are making medical cannabis products more accessible to a larger consumer base in Poland.

Methodology

Data coverage:

Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.

Modeling approach / Market size:

Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.